Viewing Study NCT04064827

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2026-02-23 @ 6:24 AM
Study NCT ID: NCT04064827
Status: TERMINATED
Last Update Posted: 2025-12-04
First Post: 2019-08-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)
Sponsor: AbbVie
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Kidney Disease (CKD) View
None Secondary Hyperparathyroidism (SHPT) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chronic Kidney Disease View
None Paricalcitol View
None Hyperparathyroidism View
None Pediatric Subjects View
None Peritoneal Dialysis (PD) View
None Hemodialysis (HD) View
None Intact parathyroid hormone (iPTH) View